Brief: Karuna Therapeutics reports Q4 net loss per share of USD 2.22
23/02/2023 12:52
Feb 23 (Reuters) - Karuna Therapeutics Q4 net income USD -76.212 million. * Q4 EPS USD -2.22
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)